An mHealth application for chronic vascular access: A multi‐method evaluation

Author:

Ullman Amanda J.123,Larsen Emily345ORCID,Gibson Victoria12,Binnewies Sebastian6,Ohira Ryoma6,Marsh Nicole134,Mcbride Craig2,Winterbourn Karen7,Boyte Francesca4,Cunninghame Jacqueline1ORCID,Dufficy Mitchell1ORCID,Plummer Karin23,Roberts Natasha18,Takashima Mari12ORCID,Cooke Marie3,Byrnes Joshua5,Rickard Claire M.1348,Kleidon Tricia M.123

Affiliation:

1. School of Nursing, Midwifery and Social Work, Health and Behavioural Sciences The University of Queensland St Lucia Queensland Australia

2. Queensland Children's Hospital, Children's Health Queensland Hospital and Health Service South Brisbane Queensland Australia

3. School of Nursing and Midwifery Griffith University Nathan Queensland Australia

4. Nursing and Midwifery Research Centre, Royal Brisbane and Women's Hospital Herston Queensland Australia

5. Centre for Applied Health Economics Griffith University Nathan Queensland Australia

6. School of Information and Communication Technology Griffith University Gold Coast Queensland Australia

7. Parenteral Nutrition Down Under Randwick New South Wales Australia

8. Metro North Health Service Herston Queensland Australia

Abstract

AbstractBackgroundHealthcare consumers require diverse resources to assist their navigation of complex healthcare interactions, however, these resources need to be fit for purpose.AimIn this study, we evaluated the utility, usability and feasibility of children, families and adults requiring long‐term intravenous therapy using a recently developed mobile health application (App), intravenous (IV) Passport.DesignMulti‐site, parallel, multi‐method, prospective cohort study.MethodsA multi‐site, multi‐method study was carried out in 2020–2021, with 46 participants (20 adults, 26 children/family) reporting on their experiences surrounding the use of the IV Passport for up to 6 months.ResultsOverall, utility rates were acceptable, with 78.3% (N = 36) using the IV Passport over the follow‐up period, with high rates of planned future use for those still active in the project (N = 21; 73%), especially in the child/family cohort (N = 13; 100%). Acceptability rates were high (9/10; IQR 6.5–10), with the IV Passport primarily used for documenting new devices and complications. Thematic analysis revealed three main themes (and multiple subthemes) in the qualitative data: Advocacy for healthcare needs, Complexity of healthcare and App design and functionality.ConclusionSeveral recommendations were made to improve the end‐user experience including ‘how to’ instructions; and scheduling functionality for routine care.Implications for the Profession and/or Patient CareThe IV Passport can be safely and appropriately integrated into healthcare, to support consumers.ImpactPatient‐/parent‐reported feedback suggests the Intravenous Passport is a useful tool for record‐keeping, and positive communication between patients/parents, and clinicians.Reporting MethodNot applicable.Patient ContributionConsumers reported their experiences surrounding the use of the IV Passport for up to 6 months.

Funder

Royal Brisbane and Women's Hospital Foundation

National Health and Medical Research Council

Publisher

Wiley

Reference39 articles.

1. Safe, sound and desirable: Development of mHealth apps under the stress of rapid life cycles;Albrecht U.‐V.;Mhealth,2017

2. Australian Commission on Safety and Quality in Health Care.Australian Hospital Patient Experience Question Set Australian Commission on Safety and Quality in Health Care Editor.2020 Australian government: Canberra Australia.

3. Chronic Central Venous Access: From Research Consensus Panel to National Multistakeholder Initiative

4. Contemporary Vascular Smartphone Medical Applications

5. Not "just" an intravenous line: Consumer perspectives on peripheral intravenous cannulation (PIVC). An international cross-sectional survey of 25 countries

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3